Dtsch Med Wochenschr 2017; 142(16): 1231-1247
DOI: 10.1055/s-0043-108953
CME-Fortbildung
© Georg Thieme Verlag KG Stuttgart · New York

Hyponatriämie: Differenzialdiagnose und Therapie

Hyponatremia: Differential Diagnosis and Treatment
Heiner Mönig
,
Alexander Arlt
Further Information

Publication History

Publication Date:
15 August 2017 (online)

Abstract

Hyponatremia is the most common electrolyte abnormality seen in hospitalized patients, with up to 30 % having a plasma sodium concentration below 135 mmol/l. It is now clear that the clinical problem extends beyond the neurological symptoms, which can be explained by intracerebral osmotic fluid shifts and brain edema. Instead, chronic hyponatremia is associated with impaired gait stability and an increased risk of bone fragility fractures. Moreover, hyponatremia has been demonstrated to be an indicator of poor prognosis in a variety of conditions.

Hyponatremia can be a life-threatening disorder due to increased intracranial pressure, thus requiring prompt and efficacious treatment. However, overly rapid correction may be complicated by osmotic demyelination syndrome with catastrophic clinical sequelae, i. e., spastic quadriparesis, or even coma or death.

To avoid inappropriate treatment, the underlying pathophysiology in each case as well as the time course (acute vs. chronic) and the clinical and biochemical severity must be considered.

The purpose of this review is to provide the reader with a systematic approach to the correct diagnosis and management of hyponatremia based on available European and international guidelines.

Hyponatriämie ist die häufigste Elektrolytstörung bei stationär aufgenommenen Patienten. Grundzüge der Diagnostik und Therapie müssen auf jeder internistischen Notaufnahme- und Intensivstation bekannt sein. Auch in der ambulanten Versorgung sollte der Befund „Hyponatriämie“ aufmerksam zur Kenntnis genommen und weiterverfolgt werden. Der vorliegende CME-Beitrag soll die dafür notwendigen Grundkenntnisse vermitteln.

 
  • Literatur

  • 1 Upadhyay A, Jaber BL, Madias NE. Incidence and prevalence of hyponatremia. Am J Med 2006; 119 (07) 30-35
  • 2 Ayus JC, Fuentes NA, Negri AL. et al. Mild prolonged chronic hyponatremia and risk of hip fracture in the elderly. Nephrol Dial Transplant 2016; 31: 1662-1669
  • 3 Zieschang T, Wolf M, Vellappallil T. et al. Assoziation von Hyponatriämie, Delirrisiko und Mortalität. Dtsch Arztebl Int 2016; 113: 855-862
  • 4 Burst V, Hensen J. Hyponatriämie – häufig und komplex. Dtsch med Wochenschr 2015; 140: 608-611
  • 5 Spasovski G, Vanholder R, Allolio B. et al. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Eur J Endocrinol 2014; 170: G1-G47
  • 6 Gross P, Benzing T, Hensen J. et al. Praxisnaher Leitfaden zum Vorgehen bei Hyponatriämie. Dtsch med Wochenschr 2011; 136: 1728-1732
  • 7 Fenske W, Störk S, Blechschmidt A. et al. Copeptin in the differential diagnosis of hyponatremia. J Clin Endocrinol Metab 2009; 94: 123-129
  • 8 Maesaka JK, Imbriano L, Mattana J. et al. Differentiating SIADH from cerebral/renal salt wasting: failure of the volume approach and need for a new approach to hyponatremia. J Clin Med 2014; 3: 1373-1385
  • 9 Schwartz WB, Bennett W, Curelop S. et al. A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone. Am J Med 1957; 23: 529-542
  • 10 Janicic N, Verbalis JG. Evaluation and management of hypo-osmolality in hospitalized patients. Endocrinol Metab Clin North Am 2003; 32: 459-481
  • 11 Nigro N, Wizeler B, Suter-Widmer I. et al. Evaluation of copeptin and commonly used laboratory parameters for the differential diagnosis of profound hyponatraemia in hospitalized patients: ‘The Co-MED Study’. Clin Endocrinol (Oxf) 2017; 86: 456-462
  • 12 Adrogue HJ, Madias NE. Hyponatremia. N Engl J Med 2000; 342: 1581-1589
  • 13 Watkins PB, Lewis JH, Kaplowitz N. et al. Clinical pattern of tolvaptan-associated liver injury in subjects with autosomal dominant polycystic kidney disease: Analysis of clinical trials database. Drug Saf 2015; 38: 1103-1113
  • 14 Verbalis JG, Grossman A, Höybye C. et al. Review and analysis of differing regulatory indications and expert panel guidelines for the treatment of hyponatremia. Curr Med Res Opin 2014; 30: 1201-1207
  • 15 Grant P, Ayuk J, Bouloux PM. et al. The diagnosis and management of inpatient hyponatraemia and SIADH. Eur J Clin Invest 2015; 45: 888-894